Multi event Drug Recall Enforcement Report Class II voluntary initiated by Pfizer Inc., originally initiated on 01-11-2016 for the product Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1013-68 The product was recalled due to failed tablet/capsule specifications: firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.. The product was distributed nationwide and the recall is currently terminated.
Recall Enforcement Reports
Recall Number |
Recall Initiation Date |
Report Date |
Recall Classification |
Quantity |
Product Description |
Recall Reason |
Status |
D-0648-2016 | 01-11-2016 | 02-10-2016 | Class II | 30,672 bottles | Lyrica (pregabalin) capsules, 50 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1013-68 | FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules. | Terminated |
D-0649-2016 | 01-11-2016 | 02-10-2016 | Class II | 116,400 bottles | Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68 | FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules. | Terminated |
Recalled Products